BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update
OrthoSpineNews
MAY 14, 2025
First quarter 2025 deferred revenues were $150,000, compared to $nil in the first quarter of 2024. million for the comparable period of 2024. per share, for the first quarter of 2024. per share, for the first quarter of 2024. The change was primarily due to a gain on the exchange of warrants in Q1-2024.
Let's personalize your content